Be sure to check our sister interview main ratings news website

Sativa Wellness Group significant growth of the business accelerated through Q3

Sativa Wellness Group Inc (AQSE:SWEL) has announced today a second quarterly profit in Q3 2021. The Company has filed the Financial Statements and Management’s Discussion and Analysis for Q3 September 2021, demonstrating continued strong growth. All amounts unless stated otherwise are presented in British Pounds (GBP).

The Company has continued to exceed all targets set to meet its ambition of diversifying within the Health and Wellness sector by offering wellness testing through a network of Goodbody clinics. As at the date of this announcement, the Company has over 80 clinics in operation and the Company is rolling out a range of additional tests to supplement its COVID testing.

Excluding currency exchange, the profit showed a stronger operational result and materially outperformed Q2 as well as all previous quarters.

Q3 2021 Highlights compared to Q3 2020 and Q2 2021:

·    Q3 2021 Revenue 977% higher vs comparative quarter 2020.  £5.02m revenue, £4.55m more than the equivalent period the previous year, making it the highest revenue quarter since inception and the third quarter in succession to exceed the turnover of previous quarters.  This is a £1.54m or 44% increase on Q2.

·    YTD 2021 Revenue 724% higher vs comparative period in 2020. £9.88m revenue, £8.68m more than the equivalent period the previous year.

·    Q3 2021 Gross profit 990% higher vs comparative quarter 2020.  £2.68m, which is £2.43m more than the equivalent period the previous year. The gross profit percentage margin at 53% was in line with the previous year.

·    Net profit of £8k, compared to £(696K) loss in the same period the previous year.

·    Q3 2021 EBITDA £268K, compared to £(595K) negative EBITDA in the same period the previous year and £82K EBITDA in Q2.

·    German Distribution Agreement for CBD products signed with partners Lexamed GMBH

·    Announced launch of its ‘Best Price, Best Quality CBD Oil’ with Guarantee.

·    Launch of website membership scheme and new product range to include larger 30ml bottles. 

Subsequent to Q3 2021:

·    Launch of the Company’s online UK telemedical GP service.

·    Number of tests booked in a day exceeding 850 tests and £100,000

·    Number of clinics exceeding 80

Geremy Thomas, Executive Chairman, says; “I am so pleased the significant growth of the business accelerated through Q3. We are exceeding expectations and the strategy introduced earlier in the year continues to validate our mission to deliver to consumers and partners a diverse health and wellness company.  Whilst we remain cautious in managing our CBD investment, focussing on ‘Best Price, Best Quality, our work with our pharmacy partners in creating local community diagnostic hubs continues, consistent with the published NHS long-term plan”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

More articles like this

Sativa Wellness Group achieves ISO 22000 Food Safety certification

6th January 2022

Sativa Wellness Group Inc (AQSE:SWEL) has announced the successful achievement of ISO 22000 certification applicable to food safety relating to cannabis extraction at its Polish plant.  The company also successfully passed the Hazard Analysis and Critical Control Point

Men’s Health: Why don’t we talk about it?

24th December 2021

1 in 5 men die before the age of 65, 2 in 5 men don’t make it to 75, and on average men die 3.7 years before women, however sometimes it can feel like men’s health is side-lined,

Sativa Wellness Group Management Share Compensation Arrangements

23rd December 2021

Sativa Wellness Group plc (AQSE:SWEL / CNSX:SWEL) today announced certain management share compensation arrangements and amendments that have been approved by the Board of Directors with a view to both incentivising and aligning management and shareholder interests. Firstly, following an administrative

Use of Cannabidiol for the treatment of Anxiety

6th December 2021

A macro-analysis of 49 different research papers (focusing primarily on animal studies) on the effects of CBD regarding multiple anxiety or stress-oriented disorders, such as Post-Traumatic Stress Disorder, Generalised Anxiety Disorder, and Social Anxiety Disorder to name a

Sativa Wellness Group reports best week to date for bookings

6th December 2021

Sativa Wellness Group Inc (AQSE:SWEL) has announced that last week was the Company’s best week to date for bookings, with several days exceeding previous records. This meant the company exceeded £13.8m revenue in the eleven months to the

The “Runner’s High” and Endocannabinoids

2nd December 2021

A runner’s high is a sense of well-being some people experience after prolonged exercise. For decades, it was hypothesized that exercise-induced endorphin release is solely responsible for a runner’s high, but recent evidence has suggested that endocannabinoids also

CBD bioavailability and why it matters

26th November 2021

Wealth, friends, and even spouses, if lost, can be regained or acquired again somehow. But the body, once gone, will never come back- no matter how hard we try to revive the life that’s lost. Our bodies are

Finding relief from aches and pains

22nd November 2021

Everyone at some point of their life will experience some aches and pain, and it could be because of a whole range of different reasons. For some of us, that would be a bit of joint and muscle

CBD and mental health: A systematic analysis

19th November 2021

There is a lot of research about the positive effects of CBD and Mental Health.  This report is a systematic analysis of a multitude of different research papers and conducted trials with regards to CBD’s impact on a

General benefits of CBD

18th November 2021

CBD has been reported to help people in a number of ways. From pain relief, memory, and sleep to name a few, there’s a chance that we could all benefit from CBD in one way or another. So

CBD and Diabetes: How can it help?

12th November 2021

Close to 4.9 million people in the UK have been diagnosed with diabetes, with a further 850,000 people suspected to be living with undiagnosed type 2 diabetes. To add on to this, 13.6 million people in the UK

The effects of cannabidiol on cerebral blood flow

11th November 2021

The primary aim of this research paper was to investigate how CBD influences cerebral blood flow (CBF) in regions involved in memory processing. It was conducted under a randomised, crossover, double-blind design in which 15 healthy participants were

Sativa Wellness Group Report record Q3 revenues (Interview)

10th November 2021

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) CEO Mark Howells joins DirectorsTalk Interviews to discuss a record quarterly profit in Q3 2021. Mark talks us through the numbers, explains how sustainable the performance is and plans for the

Men’s Health: Why don’t we talk about it?

5th November 2021

1 in 5 men die before the age of 65, 2 in 5 men don’t make it to 75, and on average men die 3.7 years before women, however sometimes it can feel like men’s health is side-lined,

Cannabidiol’s use as chronic pain treatment

1st November 2021

This paper reviews the basic research regarding the molecular mechanism of CBD’s action with particular focus on its analgesic potential for chronic pain treatment, as well as describing the detailed analgesic and anti-inflammatory effects of CBD in various

No more posts to show

© 2022 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.